PRPH – ProPhase Labs Inc
PRPH
$0.534Name : ProPhase Labs, Inc.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $16,140,790.00
EPSttm : -1.53
ProPhase Labs, Inc.
$0.534
Float Short %
0.33
Margin Of Safety %
Put/Call OI Ratio
0.02
EPS Next Q Diff
0.17
EPS Last/This Y
EPS This/Next Y
0.67
Price
0.53
Target Price
16
Analyst Recom
1
Performance Q
-32.18
Relative Volume
1.61
Beta
-0.41
Ticker: PRPH
21 items
«
‹
of 1
›
»
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
---|---|---|---|---|---|
2025-01-23 | PRPH | 0.4999 | 0.02 | 0.00 | 1428 |
2025-01-24 | PRPH | 0.54 | 0.02 | 0.00 | 1438 |
2025-01-27 | PRPH | 0.448 | 0.02 | 0.00 | 1438 |
2025-01-28 | PRPH | 0.4534 | 0.02 | 0.00 | 1439 |
2025-01-29 | PRPH | 0.4209 | 0.02 | 0.00 | 1439 |
2025-01-30 | PRPH | 0.4128 | 0.02 | 0.00 | 1439 |
2025-01-31 | PRPH | 0.3 | 0.02 | 0.00 | 1429 |
2025-02-03 | PRPH | 0.267 | 0.02 | 0.00 | 1448 |
2025-02-04 | PRPH | 0.2351 | 0.02 | 0.00 | 1550 |
2025-02-05 | PRPH | 0.2576 | 0.02 | 0.00 | 1658 |
2025-02-06 | PRPH | 0.251 | 0.02 | 0.00 | 1659 |
2025-02-07 | PRPH | 0.2607 | 0.02 | 0.00 | 1662 |
2025-02-10 | PRPH | 0.26 | 0.02 | 0.00 | 1667 |
2025-02-11 | PRPH | 0.2601 | 0.02 | 0.00 | 1677 |
2025-02-12 | PRPH | 0.2769 | 0.02 | 0.00 | 1677 |
2025-02-13 | PRPH | 0.355 | 0.01 | 0.01 | 1684 |
2025-02-14 | PRPH | 0.3192 | 0.01 | 0.03 | 1930 |
2025-02-18 | PRPH | 0.43 | 0.01 | 0.01 | 1941 |
2025-02-19 | PRPH | 0.57 | 0.01 | 0.02 | 2309 |
2025-02-20 | PRPH | 0.5999 | 0.01 | 0.06 | 2697 |
2025-02-21 | PRPH | 0.5251 | 0.02 | 0.03 | 3106 |
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
21 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
---|---|---|---|---|---|
2025-01-23 | PRPH | 0.49 | 52.9 | - | -1.23 |
2025-01-24 | PRPH | 0.50 | 52.9 | - | -1.23 |
2025-01-27 | PRPH | 0.45 | 52.9 | - | -1.23 |
2025-01-28 | PRPH | 0.42 | 52.9 | - | -1.23 |
2025-01-29 | PRPH | 0.45 | 52.9 | - | -1.23 |
2025-01-30 | PRPH | 0.42 | 52.9 | - | -1.23 |
2025-01-31 | PRPH | 0.26 | 52.9 | - | -1.23 |
2025-02-03 | PRPH | 0.27 | 52.9 | - | -1.23 |
2025-02-04 | PRPH | 0.24 | 52.9 | - | -1.23 |
2025-02-05 | PRPH | 0.26 | 52.9 | - | -1.23 |
2025-02-06 | PRPH | 0.26 | 52.9 | - | -1.23 |
2025-02-07 | PRPH | 0.26 | 52.9 | - | -1.23 |
2025-02-10 | PRPH | 0.26 | 52.9 | - | -1.23 |
2025-02-11 | PRPH | 0.28 | 52.9 | - | -1.23 |
2025-02-12 | PRPH | 0.29 | 52.9 | - | -1.23 |
2025-02-13 | PRPH | 0.34 | 52.9 | - | -1.23 |
2025-02-14 | PRPH | 0.32 | 52.9 | - | -1.23 |
2025-02-18 | PRPH | 0.43 | 52.9 | - | -1.23 |
2025-02-19 | PRPH | 0.57 | 52.9 | - | -1.23 |
2025-02-20 | PRPH | 0.60 | 52.9 | - | -1.23 |
2025-02-21 | PRPH | 0.53 | 52.9 | - | -1.23 |
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
21 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
---|---|---|---|---|
2025-01-23 | PRPH | 0.00 | 2.67 | 0.48 |
2025-01-24 | PRPH | 0.00 | 2.67 | 0.48 |
2025-01-27 | PRPH | 0.00 | 13.29 | 0.48 |
2025-01-28 | PRPH | 0.00 | 13.29 | 0.57 |
2025-01-29 | PRPH | 0.00 | 13.29 | 0.57 |
2025-01-30 | PRPH | 0.00 | 13.29 | 0.57 |
2025-01-31 | PRPH | 0.00 | 13.29 | 0.57 |
2025-02-03 | PRPH | 0.00 | 11.03 | 0.57 |
2025-02-04 | PRPH | 0.00 | 11.03 | 0.57 |
2025-02-05 | PRPH | 0.00 | 11.03 | 0.57 |
2025-02-06 | PRPH | 0.00 | 11.03 | 0.45 |
2025-02-07 | PRPH | 0.00 | 11.03 | 0.45 |
2025-02-10 | PRPH | 0.00 | 10.34 | 0.45 |
2025-02-11 | PRPH | 0.00 | 10.34 | 0.45 |
2025-02-12 | PRPH | 0.00 | 10.34 | 0.33 |
2025-02-13 | PRPH | 0.00 | 10.34 | 0.33 |
2025-02-14 | PRPH | 0.00 | 10.34 | 0.33 |
2025-02-18 | PRPH | 0.00 | 12.11 | 0.33 |
2025-02-19 | PRPH | 0.00 | 12.11 | 0.33 |
2025-02-20 | PRPH | 0.00 | 12.11 | 0.33 |
2025-02-21 | PRPH | 0.00 | 12.11 | 0.33 |
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
21 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
-0.35
Avg. EPS Est. Current Quarter
-0.24
Avg. EPS Est. Next Quarter
-0.18
Insider Transactions
Institutional Transactions
12.11
Beta
-0.41
Average Sales Estimate Current Quarter
5
Average Sales Estimate Next Quarter
2
Fair Value
Quality Score
23
Growth Score
37
Sentiment Score
51
Actual DrawDown %
96.7
Max Drawdown 5-Year %
-98.4
Target Price
16
P/E
Forward P/E
PEG
P/S
1.25
P/B
0.27
P/Free Cash Flow
EPS
-1.5
Average EPS Est. Cur. Y
-1.23
EPS Next Y. (Est.)
-0.56
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-217.64
Relative Volume
1.61
Return on Equity vs Sector %
-92
Return on Equity vs Industry %
-83.3
EPS 1 7Days Diff
-0.3
EPS 1 30Days Diff
-0.31
EBIT Estimation
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 113
ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. It offers contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular and DNA testing services, as well as personal genomics products and services. In addition, the company involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.
stock quote shares PRPH – ProPhase Labs Inc Stock Price stock today
news today PRPH – ProPhase Labs Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch PRPH – ProPhase Labs Inc yahoo finance google finance
stock history PRPH – ProPhase Labs Inc invest stock market
stock prices PRPH premarket after hours
ticker PRPH fair value insiders trading